微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -5.3% | -181.16% | -64.09% | 47/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -3.23% | -134.88% | -113.91% | 46/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -1.51% | -124.59% | 50.33% | 42/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -3.04% | -114.4% | -146.55% | 41/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 6.53% | -66.22% | -29.48% | 21/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 9.26% | -15.28% | 50.81% | 8/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 6.14% | 8.67% | -70.91% | 3/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 21.11% | -2.99% | 9.21% | 9/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 19.33% | 28.27% | 76.85% | 10/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 10.93% | 17.53% | 93.45% | 11/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 5.65% | 43.4% | -74.03% | 7/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 21.76% | 86.46% | 44.39% | 10/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 15.07% | 107.86% | 62.04% | 10/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 9.3% | 115.78% | 136.04% | 14/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 3.94% | 159.21% | -66.24% | 11/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 11.67% | -4.58% | 60.97% | 26/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 7.25% | -38.4% | 68.21% | 18/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 4.31% | -37.63% | 183.55% | 17/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 1.52% | 2% | -87.57% | 13/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 12.23% | -26.68% | 3.91% | 24/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 11.77% | 2% | 70.33% | 11/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 6.91% | 2% | -58.57% | 10/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2018-12-31 | 16.68% | 33.44% | 33.44% | 12/51 | -0.6% | 南华生物 | 82.46% | 行业排名> |
| 2017-12-31 | 12.5% | -56.46% | -56.46% | 13/51 | 1.73% | 南华生物 | 48.41% | 行业排名> |
| 2016-12-31 | 28.71% | -45.38% | -45.38% | 3/51 | 23.06% | 万邦医药 | 106.72% | 行业排名> |
| 2015-12-31 | 52.56% | 2% | 2% | 2/51 | 22.23% | 国际医学 | 46.66% | 行业排名> |